Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S D Roger

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Internal Medicine Journal|June 6, 2007
Research degrees for medical graduatesS D Roger
International Journal of Clinical Practice|September 17, 2008
Extended administration of erythropoiesis-stimulating agents for optimising the management of renal anaemia: what is the evidence?S D Roger
Journal of Clinical Pharmacy and Therapeutics|October 7, 2008
Biosimilars: it's not as simple as cost aloneS D Roger, D Goldsmith
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 1, 1991
Effects of erythropoietin on blood pressureA E Raine, S D Roger
Lancet (London, England)|June 29, 1991
Phlebotomy for erythropoietin-associated malignant hypertensionS D Roger, I C Macdougall, A E Raine
Clinical Nephrology|February 1, 1993
Autonomic dysfunction and the development of hypertension in patients treated with recombinant human erythropoietin (r-HuEPO)S D Roger, L R Baker, A E Raine
Lancet (London, England)|June 22, 1991
Possible relation between restless legs and anaemia in renal dialysis patientsS D Roger, D C Harris, J H Stewart
Nephron|January 1, 1991
Desferrioxamine enhances the haemopoietic response to erythropoietin, but adverse events are commonS D Roger, J H Stewart, D C Harris
Australian and New Zealand Journal of Medicine|December 1, 1990
Lead intoxication in an anuric patient: management by intraperitoneal EDTAS D Roger, D Crimmins, C Yiannikas, et al.
Transplantation Proceedings|October 1, 1989
Sensitization and renal transplantation in New South WalesS D Roger, M Hibbins, J Wright, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Internal Medicine Journal|June 6, 2007
Research degrees for medical graduatesS D Roger
International Journal of Clinical Practice|September 17, 2008
Extended administration of erythropoiesis-stimulating agents for optimising the management of renal anaemia: what is the evidence?S D Roger
Journal of Clinical Pharmacy and Therapeutics|October 7, 2008
Biosimilars: it's not as simple as cost aloneS D Roger, D Goldsmith
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 1, 1991
Effects of erythropoietin on blood pressureA E Raine, S D Roger
Lancet (London, England)|June 29, 1991
Phlebotomy for erythropoietin-associated malignant hypertensionS D Roger, I C Macdougall, A E Raine
Clinical Nephrology|February 1, 1993
Autonomic dysfunction and the development of hypertension in patients treated with recombinant human erythropoietin (r-HuEPO)S D Roger, L R Baker, A E Raine
Lancet (London, England)|June 22, 1991
Possible relation between restless legs and anaemia in renal dialysis patientsS D Roger, D C Harris, J H Stewart
Nephron|January 1, 1991
Desferrioxamine enhances the haemopoietic response to erythropoietin, but adverse events are commonS D Roger, J H Stewart, D C Harris
Australian and New Zealand Journal of Medicine|December 1, 1990
Lead intoxication in an anuric patient: management by intraperitoneal EDTAS D Roger, D Crimmins, C Yiannikas, et al.
Transplantation Proceedings|October 1, 1989
Sensitization and renal transplantation in New South WalesS D Roger, M Hibbins, J Wright, et al.
Pageof 3